{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:13:44Z","timestamp":1791000824960,"version":"4.1.0"},"reference-count":169,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s40618-020-01208-6","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T16:02:32Z","timestamp":1584028952000},"page":"885-899","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":155,"title":["The interplay between thyroid and liver: implications for clinical practice"],"prefix":"10.1007","volume":"43","author":[{"given":"E.","family":"Piantanida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ippolito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Masiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Premoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Cusini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Rosetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Sabatino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Segato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Trimarchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Bartalena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. L.","family":"Tanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,12]]},"reference":[{"key":"1208_CR1","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41574-019-0218-2","volume":"15","author":"C Luongo","year":"2019","unstructured":"Luongo C, Dentice M, Salvatore D (2019) Deiodinases and their intricate role in thyroid hormone homeostasis. Nat Rev Endocrinol 15:479\u2013488","journal-title":"Nat Rev Endocrinol"},{"key":"1208_CR2","first-page":"442","volume-title":"Encyclopedia of endocrine diseases","author":"L Bartalena","year":"2018","unstructured":"Bartalena L, Piantanida E (2018) Serum thyroid hormone-binding proteins. In: Huhtaniemi I, Martini L (eds) Encyclopedia of endocrine diseases, 2nd edn. Elsevier, Oxford, pp 442\u2013447","edition":"2"},{"key":"1208_CR3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1023\/A:1005674211976","volume":"46","author":"J Inkinen","year":"2001","unstructured":"Inkinen J, Sand J, Arvola P, P\u00f6rsti I, Nordback I (2001) Direct effect of thyroxine on pig sphincter of Oddi contractility. Dig Dis Sci 46:182\u2013186","journal-title":"Dig Dis Sci"},{"key":"1208_CR4","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1080\/00365520212492","volume":"37","author":"J Sand","year":"2002","unstructured":"Sand J, Aittom\u00e4ki S, P\u00f6rsti I (2002) Mechanism of the prorelaxing effect of thyroxine on the sphincter of Oddi. Scand J Gastroenterol 37:667\u2013673","journal-title":"Scand J Gastroenterol"},{"key":"1208_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1365-2265.1991.tb01739.x","volume":"34","author":"JV Parle","year":"1991","unstructured":"Parle JV, Franklin JA, Cross KW, Jones SC, Sheppard MC (1991) Prevalence and follow-up of abnormal thyrotropin (TSH) concentrations in the elderly in the United Kindom. Clin Endocrinol (Oxf) 34:77\u201383","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1208_CR6","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1210\/jcem.87.2.8182","volume":"87","author":"JG Hollowell","year":"2002","unstructured":"Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE (2002) Serum TSH, T(4), and thyroid antibodies in the United States population (1988\u20131994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87:489\u2013499","journal-title":"J Clin Endocrinol Metab"},{"key":"1208_CR7","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1365-2265.2007.03068.x","volume":"68","author":"G Targher","year":"2008","unstructured":"Targher G, Montagnana M, Salvagno G (2008) Association between serum TSH, free T4 and serum liver enzyme activities in a large cohort of unselected outpatients. Clin Endocrinol 68:481\u2013484","journal-title":"Clin Endocrinol"},{"key":"1208_CR8","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1055\/s-2008-1041234","volume":"11","author":"MA Laycock","year":"1991","unstructured":"Laycock MA, Pascuzzi RM (1991) The neuromuscular effects of hypothyroidism. Semin Neurol 11:288\u2013294","journal-title":"Semin Neurol"},{"key":"1208_CR9","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1365-2265.2011.04016.x","volume":"75","author":"C Xu","year":"2011","unstructured":"Xu C, Xu L, Yu C, Miao M, Li Y (2011) Association between thyroid function and nonalcoholic fatty liver disease in euthyroid elderly Chinese. Clin Endocrinol (Oxford) 75:240\u2013246","journal-title":"Clin Endocrinol (Oxford)"},{"key":"1208_CR10","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1210\/jc.2016-1300","volume":"101","author":"A Bano","year":"2016","unstructured":"Bano A, Chaker L, Plompen EP, Hofman A, Dehghan A, Franco OH, Janssen HL, Darwish Murad S, Peeters RP (2016) Thyroid function and the risk of nonalcoholic fatty liver disease: the Rotterdam study. J Clin Endocrinol Metab 101:3204\u20133211","journal-title":"J Clin Endocrinol Metab"},{"key":"1208_CR11","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1172\/JCI60580","volume":"122","author":"RA Sinha","year":"2012","unstructured":"Sinha RA, You SH, Zhou J, Siddique MM, Bay BH, Zhu X, Privalsky ML, Cheng SY, Stevens RD, Summers SA, Newgard CB, Lazar MA, Yen PM (2012) Thyroid hormone stimulate hepatic lipid catabolism via activation of autophagy. J Clin Invest 122:2428\u20132438","journal-title":"J Clin Invest"},{"key":"1208_CR12","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.tem.2014.08.001","volume":"25","author":"CD Fuchs","year":"2014","unstructured":"Fuchs CD, Claudel T, Trauner M (2014) Role of metabolic lipases and lipolytic metabolities in the pathogenesis of NAFLD. Trends Endocrinol Metab 25:576\u2013585","journal-title":"Trends Endocrinol Metab"},{"key":"1208_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1743-7075-3-13","volume":"3","author":"H Yu","year":"2006","unstructured":"Yu H, Yang Y, Zhang M, Lu H, Zhang J, Wang H, Cianflone K (2006) Thyroid status influence on adiponectin, acylation stimulating protein (ASP) and complement C3 in hyperthyroid and hypothyroid subjects. Nutr Metab (London) 3:13\u201320","journal-title":"Nutr Metab (London)"},{"key":"1208_CR14","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1002\/hep.20896","volume":"42","author":"G Musso","year":"2005","unstructured":"Musso G, Gambino R, Durazzo M, Biroli G, Carello M, Fag\u00e0 E, Pacini G, De Michieli F, Rabbione L, Premoli A, Cassader M, Pagano G (2005) Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease. Hepatology 42:1175\u20131183","journal-title":"Hepatology"},{"key":"1208_CR15","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.dld.2018.12.014","volume":"51","author":"A Lonardo","year":"2019","unstructured":"Lonardo A, Ballestri S, Mantovani A, Nascimbeni F, Lugari S, Targher G (2019) Pathogenesis of hypothyroidism-induced NAFLD: evidence for a distinct entity? Dig Liv Dis 51:462\u2013470","journal-title":"Dig Liv Dis"},{"key":"1208_CR16","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1089\/thy.2018.0664","volume":"29","author":"RA Sinha","year":"2019","unstructured":"Sinha RA, Bruinstroop E, Singh BK, Yen PM (2019) Nonalcoholic fatty liver disease and hypercholesterolemia: roles of thyroid hormones, metabolites, and agonists. Thyroid 29:1173\u20131191","journal-title":"Thyroid"},{"key":"1208_CR17","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1111\/j.1572-0241.2004.30444.x","volume":"99","author":"LA Adams","year":"2004","unstructured":"Adams LA, Lindor KD, Angulo P (2004) The prevalence of autoantibodies and autoimmune hepatitis in patients with non-alcoholic fatty liver disease. Am J Gastroenterol 99:1316\u20131320","journal-title":"Am J Gastroenterol"},{"key":"1208_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0889-8553(21)00531-8","volume":"20","author":"AK Diehl","year":"1991","unstructured":"Diehl AK (1991) Epidemiology and natural history of gallstone disease. Gastroenterol Clin North Am 20:1\u201319","journal-title":"Gastroenterol Clin North Am"},{"key":"1208_CR19","doi-asserted-by":"publisher","first-page":"5530","DOI":"10.3748\/wjg.v11.i35.5530","volume":"11","author":"H V\u00f6lzke","year":"2005","unstructured":"V\u00f6lzke H, Robinson DM, John U (2005) Association between thyroid function and gallstone disease. World J Gastroenterol 11:5530\u20135534","journal-title":"World J Gastroenterol"},{"key":"1208_CR20","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1067\/msy.2003.77","volume":"133","author":"J Laukkarinen","year":"2003","unstructured":"Laukkarinen J, Sand J, Saaristo R, Salmi J, Turjanmaa V, Vehkalahti P, Nordback I (2003) Is bile flow reduced in patients with hypothyroidism? Surgery 133:288\u2013293","journal-title":"Surgery"},{"key":"1208_CR21","first-page":"919","volume":"47","author":"J Inkinen","year":"2000","unstructured":"Inkinen J, Sand J, Nordback I (2000) Association between common bile duct stones and treated hypothyroidism. Hepatogastroenterology 47:919\u2013921","journal-title":"Hepatogastroenterology"},{"key":"1208_CR22","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1210\/jc.2007-1316","volume":"92","author":"J Laukkarinen","year":"2007","unstructured":"Laukkarinen J, Kiudelis G, Lempinen M, R\u00e4ty S, Pelli H, Sand J, Kemppainen E, Haglund C, Nordback I (2007) Increased prevalence of subclinical hypothyroidism in common bile duct stone patients. J Clin Endocrinol Metab 92:4260\u20134264","journal-title":"J Clin Endocrinol Metab"},{"key":"1208_CR23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.4103\/0973-0354.159534","volume":"13","author":"S Sidduri","year":"2016","unstructured":"Sidduri S, Hanmayyagari B, Bongi V, Ayyagari M, Venkata S (2016) Prevalence of hypothyroidism in common bile duct stone patients. Thyroid Res Pract 13:57\u201362","journal-title":"Thyroid Res Pract"},{"key":"1208_CR24","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/S0140-6736(17)30703-1","volume":"390","author":"L Chaker","year":"2017","unstructured":"Chaker L, Bianco AC, Jonklaas J, Peeters RP (2017) Hypothyroidism. Lancet 390:1550\u20131562","journal-title":"Lancet"},{"key":"1208_CR25","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1136\/pmj.76.897.424","volume":"76","author":"N Thobe","year":"2000","unstructured":"Thobe N, Pilger P, Jones MP (2000) Primary hypothyroidism masquerading as hepatic encephalopathy: case report and review of the literature. Postgrad Med J 76:424\u2013426","journal-title":"Postgrad Med J"},{"key":"1208_CR26","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1210\/endo-123-5-2167","volume":"123","author":"J Marti","year":"1988","unstructured":"Marti J, Portles M, Jimenez-Nacher I, Cabo J, Jorda A (1988) Effect of thyroid hormones on urea biosynthesis and related processes in rat liver. Endocrinology 123:2167\u20132174","journal-title":"Endocrinology"},{"key":"1208_CR27","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s11606-007-0131-6","volume":"22","author":"D Rimar","year":"2007","unstructured":"Rimar D, Kruzel-Davila E, Dori G, Baron E, Bitterman H (2007) Hyperammonemic coma - barking up the wrong tree. J Gen Intern Med 22:549\u2013552","journal-title":"J Gen Intern Med"},{"key":"1208_CR28","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1001\/archinte.1965.03870020023008","volume":"116","author":"C Watanakunakorn","year":"1965","unstructured":"Watanakunakorn C, Hodges RE, Evans TC (1965) Myxedema: a study of 400 cases. Arch Intern Med 116:183\u2013190","journal-title":"Arch Intern Med"},{"key":"1208_CR29","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1056\/NEJM197908303010902","volume":"301","author":"HH Parving","year":"1979","unstructured":"Parving HH, Hansen JM, Nielsen SL, Rossing N, Munck O, Lassen NA (1979) Mechanisms of edema formation in myxedema increased protein extravasation and relatively slow lymphatic drainage. N Engl J Med 301:460\u2013465","journal-title":"N Engl J Med"},{"key":"1208_CR30","first-page":"949","volume":"121","author":"JP Bonvalet","year":"1970","unstructured":"Bonvalet JP, David R, Baglin A (1970) Hatt PY (1970) Myxedema with inappropriate antidiuresis and hyperaldosteronism. Ann Intern Med 121:949\u2013955","journal-title":"Ann Intern Med"},{"key":"1208_CR31","doi-asserted-by":"publisher","first-page":"315","DOI":"10.7326\/0003-4819-146-4-200702200-00021","volume":"146","author":"RN Khairy","year":"2007","unstructured":"Khairy RN, Mullen KD (2007) Hypothyroidism as a mimic of liver failure in a patient with cirrhosis. Ann Intern Med 146:315\u2013316","journal-title":"Ann Intern Med"},{"key":"1208_CR32","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/nrendo.2013.193","volume":"9","author":"L Bartalena","year":"2013","unstructured":"Bartalena L (2013) Diagnosis and management of Graves disease: a global overview. Nat Rev Endocrinol 9:724\u2013734","journal-title":"Nat Rev Endocrinol"},{"key":"1208_CR33","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.amjmed.2011.03.001","volume":"124","author":"GJ Kahaly","year":"2011","unstructured":"Kahaly GJ, Grebe SK, Lupo MA, McDonald N, Sipos JA (2011) Graves\u2019 disease: diagnostic and therapeutic challenges (multimedia activity). Am J Med 124:S2\u2013S3","journal-title":"Am J Med"},{"key":"1208_CR34","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1089\/thy.2016.0229","volume":"26","author":"DS Ross","year":"2016","unstructured":"Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, Rivkees SA, Samuels M, Sosa JA, Stan MN, Walter MA (2016) 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 26:1343\u20131421","journal-title":"Thyroid"},{"key":"1208_CR35","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/S0140-6736(02)45227-0","volume":"1","author":"SO Habershon","year":"1874","unstructured":"Habershon SO (1874) Exophtalmic goiter, heart disease, jaundice: death. Lancet 1:510\u2013512","journal-title":"Lancet"},{"key":"1208_CR36","first-page":"1071","volume":"89","author":"MJ Huang","year":"1994","unstructured":"Huang MJ, Li KL, Wei JS (1994) Sequential liver and bone biochemical changes in hyperthyroidism: prospective controlled follow-up study. Am J Gastroenterol 89:1071\u20131076","journal-title":"Am J Gastroenterol"},{"key":"1208_CR37","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/6087135","author":"KA Baagar","year":"2017","unstructured":"Baagar KA, Siddique MA, Ahmed S (2017) Atypical complications of Graves\u2019 disease: a case report and literature review. Case Rep Endocrinol. https:\/\/doi.org\/10.1155\/2017\/6087135","journal-title":"Case Rep Endocrinol"},{"key":"1208_CR38","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1111\/j.1368-5031.2005.00611.x","volume":"59","author":"S Aydemir","year":"2005","unstructured":"Aydemir S, Bayraktaroglu T, Demircan N, Sert M, A\u00e7ikgoz S, Tekin IO, Ustundag Y (2005) Effect of hyperthyroidism and propylthiouracil treatment on liver biochemical tests. Int J Clin Pract 59:1304\u20131308","journal-title":"Int J Clin Pract"},{"key":"1208_CR39","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1097\/00004836-199704000-00013","volume":"24","author":"A G\u00fcrlek","year":"1997","unstructured":"G\u00fcrlek A, \u00c7obankara V, Bayraktar M (1997) Liver tests in hyperthyroidism: effect of antithyroid therapy. J Clin Gastroenterol 24:180\u2013183","journal-title":"J Clin Gastroenterol"},{"key":"1208_CR40","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1089\/thy.2007.0189","volume":"18","author":"S Kubota","year":"2008","unstructured":"Kubota S, Amino N, Matsumoto Y, Ikeda N, Morita S, Kudo T, Ohye H, Nishihara E, Ito M, Fukata S, Miyauchi A (2008) Serial changes in liver function test in patients with thyrotoxicosis induced by Graves\u2019 disease and painless thyroiditis. Thyroid 18:283\u2013287","journal-title":"Thyroid"},{"key":"1208_CR41","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1172\/JCI102338","volume":"29","author":"JD Myers","year":"1950","unstructured":"Myers JD, Brannon ES, Holland BC (1950) A correlative study of the cardiac output and the hepatic circulation in hyperthyroidism. J Clin Invest 29:1069\u20131077","journal-title":"J Clin Invest"},{"key":"1208_CR42","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1002\/hep.20085","volume":"39","author":"G Upadhyay","year":"2004","unstructured":"Upadhyay G, Singh R, Kumar A, Kumar S, Kapoor A, Godbole MM (2004) Severe hyperthyroidism induce mytochondria mediated apoptosis in rat liver. Hepatology 39:1120\u20131130","journal-title":"Hepatology"},{"key":"1208_CR43","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1159\/000469364","volume":"34","author":"S Benvenga","year":"1985","unstructured":"Benvenga S, Melluso R, Vermiglio F, Trimarchi F (1985) Gamma-glutamyltranspeptidase and alkaline phosphatase serum activities: their relations to the outcome of Graves\u2019 disease. Enzyme 34:64\u201370","journal-title":"Enzyme"},{"key":"1208_CR44","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1177\/014107687807100307","volume":"71","author":"GR Doran","year":"1978","unstructured":"Doran GR (1978) Serum enzyme disturbances in thyrotoxicosis and myxoedema. J R Soc Med 71:189\u2013194","journal-title":"J R Soc Med"},{"key":"1208_CR45","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1093\/milmed\/143.8.548","volume":"143","author":"P Thompson","year":"1978","unstructured":"Thompson P, Strum D, Boehm T, Wartofsky L (1978) Abnormalities of liver function tests in thyrotoxicosis. Mil Med 143:548\u2013551","journal-title":"Mil Med"},{"key":"1208_CR46","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1001\/archinte.1982.00340140081015","volume":"142","author":"F Azizi","year":"1982","unstructured":"Azizi F (1982) Gamma-glutamyl transpeptidase levels in thyroid disease. Arch Intern Med 142:79\u201381","journal-title":"Arch Intern Med"},{"key":"1208_CR47","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1600-0676.1991.tb00516.x","volume":"11","author":"J Sola","year":"1991","unstructured":"Sola J, Pardo-Mind\u00e1n FJ, Zozaya J, Quiroga J, Sangro B, Prieto J (1991) Liver changes in patients with hyperthyroidism. Liver 11:193\u2013197","journal-title":"Liver"},{"key":"1208_CR48","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/0002-9343(71)90220-8","volume":"50","author":"FM Klion","year":"1971","unstructured":"Klion FM, Segal R, Schaffner F (1971) The effect of altered thyroid function on the ultrastructure of the human liver. Am J Med 50:317\u2013324","journal-title":"Am J Med"},{"key":"1208_CR49","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1210\/endo.136.8.7628392","volume":"136","author":"B Kalderon","year":"1995","unstructured":"Kalderon B, Hermesh O, Bar-Tana J (1995) Mitochondrial permeability transition is induced by in vivo thyroid hormone treatment. Endocrinology 136:3552\u20133556","journal-title":"Endocrinology"},{"key":"1208_CR50","first-page":"575","volume":"107","author":"A Sousa","year":"2015","unstructured":"Sousa A, P\u00e9rez-Rodr\u00edguez MT, P\u00e1ramo C, \u00c1lvarez E, Rivera A (2015) Severe acute liver failure and thyrotoxicosis: an uncommon association. Rev Espanola Enferm Dig 107:575\u2013576","journal-title":"Rev Espanola Enferm Dig"},{"key":"1208_CR51","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40842-015-0012-6","volume":"1","author":"SA Soleimanpour","year":"2015","unstructured":"Soleimanpour SA (2015) Fulminant liver failure associated with delayed identification of thyroid storm due to heterophile antibodies. Clin Diabetes Endocrinol 1:12","journal-title":"Clin Diabetes Endocrinol"},{"key":"1208_CR52","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/00004836-199204000-00010","volume":"14","author":"TL Fong","year":"1992","unstructured":"Fong TL, McHutchinson JG, Reynolds TB (1992) Hyperthyroidism and hepatic dysfunction. A case series analysis. J Clin Gastroenterol 14:240\u2013244","journal-title":"J Clin Gastroenterol"},{"key":"1208_CR53","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1097\/00004836-199912000-00004","volume":"29","author":"AM Choudhary","year":"1999","unstructured":"Choudhary AM, Roberts I (1999) Thyroid storm presenting with liver failure. J Clin Gastroenterol 29:318\u2013321","journal-title":"J Clin Gastroenterol"},{"key":"1208_CR54","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1097\/00004836-198808000-00013","volume":"10","author":"BA Runyon","year":"1988","unstructured":"Runyon BA (1988) Cardiac ascites: a characterization. J Clin Gastroenterol 10:410\u2013412","journal-title":"J Clin Gastroenterol"},{"key":"1208_CR55","first-page":"P294","volume":"13","author":"JJ Mettayll","year":"2007","unstructured":"Mettayll JJ, Abouglila K (2007) Thyroid storm precipitated by trauma: a rare presentation with right heart failure and liver dysfunction. Endocr Abstr 13:P294","journal-title":"Endocr Abstr"},{"key":"1208_CR56","doi-asserted-by":"publisher","first-page":"564","DOI":"10.2169\/naika.77.564","volume":"77","author":"T Inoue","year":"1988","unstructured":"Inoue T, Tanigawa K, Furuya H (1988) A case of thyroid crisis complicated with acute hepatic failure. Nippon Naika Gakkai Zasshi 77:564\u2013567","journal-title":"Nippon Naika Gakkai Zasshi"},{"key":"1208_CR57","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1378\/chest.118.3.877","volume":"118","author":"Y-Z Jiang","year":"2000","unstructured":"Jiang Y-Z, Hutchinson KA, Bartelloni P, Manthous CA (2000) Thyroid storm presenting as multiple organ dysfunction syndrome. Chest 118:877\u2013879","journal-title":"Chest"},{"key":"1208_CR58","first-page":"SD01","volume":"11","author":"M Hasosah","year":"2017","unstructured":"Hasosah M, Alsaleem K, Qurashi M, Alzaben A (2017) Neonatal hyperthyroidism with fulminant liver failure: a case report. J Clin Diagn Res 11:SD01\u2013SD02","journal-title":"J Clin Diagn Res"},{"key":"1208_CR59","doi-asserted-by":"publisher","first-page":"183e1","DOI":"10.1016\/j.amjmed.2009.06.030","volume":"123","author":"K Boelaert","year":"2010","unstructured":"Boelaert K, Newby PR, Simmonds MJ, Holder RL, Carr-Smith JD, Heward JM, Manji N, Allahabadia A, Armitage M, Chatterjee KV, Lazarus JH, Pearce SH, Vaidya B, Gough SC, Franklyn JA (2010) Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am J Med 123:183e1\u2013183e9","journal-title":"Am J Med"},{"key":"1208_CR60","first-page":"334","volume":"7","author":"D Venkat","year":"2011","unstructured":"Venkat D, Wirtz D, Patel T (2011) Autoimmune cholangiopathy and high-output heart failure in a patient with Graves\u2019 disease. Gastroenterol Hepatol (NY) 7:334\u2013337","journal-title":"Gastroenterol Hepatol (NY)"},{"key":"1208_CR61","first-page":"233","volume":"15","author":"HJ Song","year":"2012","unstructured":"Song HJ, Xue YL, Qiu ZL (2012) Uncommon metastases from differentiated thyroid carcinoma. Hell J Nucl Med 15:233\u2013240","journal-title":"Hell J Nucl Med"},{"key":"1208_CR62","first-page":"52","volume":"27","author":"M Salvatori","year":"2004","unstructured":"Salvatori M, Perotti G, Rufini V, Maussier ML, Summaria V, Fadda G, Troncone L (2004) Solitary liver metastasis from H\u00fcrthle cell thyroid cancer: a case report and review of the literature. J Clin Invest 27:52\u201356","journal-title":"J Clin Invest"},{"key":"1208_CR63","doi-asserted-by":"publisher","first-page":"R165","DOI":"10.1530\/ERC-11-0068","volume":"18","author":"HJ Song","year":"2011","unstructured":"Song HJ, Xue YL, Xu YH, Qiu ZL (2011) Rare metastases of differentiated thyroid carcinoma: pictorial review. Endocr Relat Cancer 18:R165\u2013R174","journal-title":"Endocr Relat Cancer"},{"key":"1208_CR64","doi-asserted-by":"publisher","DOI":"10.1002\/dc.22850","author":"CJ Vandenbussche","year":"2012","unstructured":"Vandenbussche CJ, Gocke CD, Li QK (2012) Fine-needle aspiration of metastases of papillary thyroid carcinoma found in the liver. Diagn Cytopathol. https:\/\/doi.org\/10.1002\/dc.22850","journal-title":"Diagn Cytopathol"},{"key":"1208_CR65","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1089\/thy.1996.6.607","volume":"6","author":"DH Shah","year":"1996","unstructured":"Shah DH, Samuel AM (1996) Metastasis to the liver in well-differentiated carcinoma of the thyroid. Thyroid 6:607\u2013611","journal-title":"Thyroid"},{"key":"1208_CR66","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1089\/thy.1999.9.173","volume":"9","author":"Guglielmi R, Panella CM, Dottorini ME, Bizzarri GC, Todino V, Crescenzi A, Rinaldi R, Panunzi C, Rossi Z, Colombo L, Papini E","year":"1999","unstructured":"Guglielmi R, Panella CM, Dottorini ME, Bizzarri GC, Todino V, Crescenzi A, Rinaldi R, Panunzi C, Rossi Z, Colombo L, Papini E (1999) Severe thyrotoxicosis due to hyperfunctioning liver metastasis from follicular carcinoma: treatment with (131)I and interstitial laser ablation. Thyroid 9:173\u2013177","journal-title":"Thyroid"},{"key":"1208_CR67","first-page":"1088","volume":"100","author":"B Niederle","year":"1986","unstructured":"Niederle B, Roka R, Schemper M, Fritsch A, Weissel M, Ramach W (1986) Surgical treatment of distant metastases in differentiated thyroid carcinoma: indications and results. Surgery 100:1088\u20131096","journal-title":"Surgery"},{"key":"1208_CR68","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1089\/thy.2008.0080","volume":"18","author":"WJLAE Marieke","year":"2008","unstructured":"Marieke WJLAE, Wertenbroek MW, Links TP, Prins TR, Plukker JT, van der Jagt EJ, de Jong KP (2008) Radiofrequency ablation of hepatic metastases from thyroid carcinoma. Thyroid 18:1105\u20131110","journal-title":"Thyroid"},{"key":"1208_CR69","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1245\/ASO.2006.05.042","volume":"13","author":"C Are","year":"2006","unstructured":"Are C, Shaha AR (2006) Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches. Ann Surg Oncol 13:453\u2013464","journal-title":"Ann Surg Oncol"},{"key":"1208_CR70","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S0002-9610(99)00052-5","volume":"177","author":"CH Lo","year":"1999","unstructured":"Lo CH, Lam K, Wan K (1999) Anaplastic carcinoma of the thyroid. Am J Surg 177:337\u2013339","journal-title":"Am J Surg"},{"key":"1208_CR71","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12020-016-1199-8","volume":"55","author":"JV Hennessey","year":"2017","unstructured":"Hennessey JV (2017) The emergence of levothyroxine as a treatment of hypothyroidism. Endocrine 55:6\u201318","journal-title":"Endocrine"},{"key":"1208_CR72","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/archinte.1986.00360200204034","volume":"146","author":"H Shibata","year":"1968","unstructured":"Shibata H, Hayakawa H, Hirukawa M, Takadoro K, Ogata E (1968) Hypersensitivity caused by synthetic thyroid hormones in a hypothyroid patient with Hashimoto\u2019s thyroiditis. Arch Intern Med 146:1624\u20131625","journal-title":"Arch Intern Med"},{"key":"1208_CR73","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1507\/endocrj.46.579","volume":"46","author":"M Ohmori","year":"1999","unstructured":"Ohmori M, Harada K, Fujimura A, Tsuruoka S, Sugimoto K-I (1999) Levothyroxine-induced liver dysfunction in a hypothyroid patient. Endocr J 46:579\u2013583","journal-title":"Endocr J"},{"key":"1208_CR74","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s40618-016-0505-x","volume":"39","author":"L Bartalena","year":"2016","unstructured":"Bartalena L, Chiovato L, Vitti P (2016) Management of hyperthyroidism due to Graves\u2019disease: frequently asked questions and answers (if any). J Endocrinol Invest 39:1105\u20131114","journal-title":"J Endocrinol Invest"},{"key":"1208_CR75","doi-asserted-by":"publisher","first-page":"R261","DOI":"10.1530\/EJE-18-0678","volume":"179","author":"HB Burch","year":"2018","unstructured":"Burch HB, Cooper DS (2018) Antithyroid drug therapy: 70 years later. Eur J Endocrinol 179:R261\u2013R274","journal-title":"Eur J Endocrinol"},{"key":"1208_CR76","doi-asserted-by":"publisher","first-page":"424","DOI":"10.7326\/0003-4819-118-6-199303150-00005","volume":"118","author":"YF Liaw","year":"1993","unstructured":"Liaw YF, Huang MJ, Fan KD, Li KL, Wu SS, Chen TJ (1993) Hepatic injury during propylthiouracil therapy in patients with hyperthyroidism: a cohort study. Ann Intern Med 118:424\u2013428","journal-title":"Ann Intern Med"},{"key":"1208_CR77","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0140-6736(03)14073-1","volume":"362","author":"DS Cooper","year":"2003","unstructured":"Cooper DS (2003) Hyperthyroidism. Lancet 362:459\u2013468","journal-title":"Lancet"},{"key":"1208_CR78","doi-asserted-by":"publisher","first-page":"497","DOI":"10.2147\/IJWH.S100987","volume":"8","author":"SL Andersen","year":"2016","unstructured":"Andersen SL, Laurberg P (2016) Managing hyperthyroidism in pregnancy: current perspectives. Int J Womens Health 8:497\u2013504","journal-title":"Int J Womens Health"},{"key":"1208_CR79","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1089\/thy.2017.0243","volume":"28","author":"T Akamizu","year":"2018","unstructured":"Akamizu T (2018) Thyroid storm: a Japanese perspective. Thyroid 28:32\u201340","journal-title":"Thyroid"},{"key":"1208_CR80","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1572-0241.2001.03469.x","volume":"96","author":"HJ Kim","year":"2001","unstructured":"Kim HJ, Kim BH, Han YS, Yang I, Kim KJ, Dong SH, Kim HJ, Chang YW, Lee JI, Chang R (2001) The incidence and clinical characteristics of symptomatic propylthioracil-induced hepatic injury in patients with hyperthyroidism: a single-center retrospective study. Am J Gastroenterol 96:165\u2013169","journal-title":"Am J Gastroenterol"},{"key":"1208_CR81","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1056\/NEJM199510263331706","volume":"333","author":"W Lee","year":"1995","unstructured":"Lee W (1995) Drug induced hepatotoxicity. N Engl J Med 333:1118\u20131122","journal-title":"N Engl J Med"},{"key":"1208_CR82","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1210\/jc.2006-2135","volume":"92","author":"H Nakamura","year":"2007","unstructured":"Nakamura H, Noh JY, Itoh K, Fukata S, Miyauchi A, Hamada N (2007) Comparison of methimazole and propylthioracil in patients with hyperthyroidism caused by Graves\u2019 disease. J Clin Endocrinol Metab 92:2157\u20132162","journal-title":"J Clin Endocrinol Metab"},{"key":"1208_CR83","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-15-0052","author":"N Tufton","year":"2015","unstructured":"Tufton N, Hashim N, Sze C, Waterhouse M (2015) A case of thyroid storm complicated by acute hepatitis due to propylthiouracil treatment. Endocrinol Diabetes Metab Case Rep. https:\/\/doi.org\/10.1530\/EDM-15-0052","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"1208_CR84","first-page":"144","volume":"165","author":"JT Hardee","year":"1996","unstructured":"Hardee JT, Barnett AL, Thannoun A, Eghtesad B, Wheeler D, Jamal MM (1996) Propylthiouracil-induced hepatotoxicity. West J Med 165:144\u2013147","journal-title":"West J Med"},{"key":"1208_CR85","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/910636","author":"AF Carrion","year":"2010","unstructured":"Carrion AF, Czul F, Arosemena LR, Selvaggi G, Garcia MT, Tekin A, Tsakis AG, Martin P, Ghanta RK (2010) Propylthioracil-induced acute liver failure: role of liver transplantation. Int J Endocrinol. https:\/\/doi.org\/10.1155\/2010\/910636","journal-title":"Int J Endocrinol"},{"key":"1208_CR86","first-page":"1727","volume":"82","author":"K Williams","year":"1997","unstructured":"Williams K, Nayak S, Becker D, Reyes J, Burmeister LA (1997) Fifty years of experience with propylthiouracil-associated hepatotoxicity: What have we learned? J Clin Endocrinol Metab 82:1727\u20131733","journal-title":"J Clin Endocrinol Metab"},{"key":"1208_CR87","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000490384","volume":"7","author":"GJ Kahaly","year":"2018","unstructured":"Kahaly GJ, Bartalena L, Heged\u00fcs L, Leenhardt L, Poppe K, Pearce SH (2018) 2018 European Thyroid Association guideline for the management of Graves\u2019 hyperthyroidism. Eur Thyroid J 7:167\u2013186","journal-title":"Eur Thyroid J"},{"key":"1208_CR88","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s40618-019-01148-w","volume":"43","author":"M Tonacchera","year":"2020","unstructured":"Tonacchera M, Chiovato L, Bartalena L, Cavaliere AF, Vitti P (2020) Treatment of Graves\u2019 disease with thionamides: a position paper on indications and safety in pregnancy. J Endocrinol Invest 43:257\u2013265","journal-title":"J Endocrinol Invest"},{"key":"1208_CR89","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/01.SMJ.0000054690.98272.B1","volume":"97","author":"NE Mikhail","year":"2005","unstructured":"Mikhail NE (2005) Methimazole-induced cholestatic jaundice. South Med J 97:178\u2013182","journal-title":"South Med J"},{"key":"1208_CR90","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1159\/000180054","volume":"21","author":"A Vitug","year":"1985","unstructured":"Vitug A, Goldman JM (1985) Hepatotoxicity from antithyroid drugs. Horm Res 21:229\u2013234","journal-title":"Horm Res"},{"key":"1208_CR91","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/00042737-199603000-00018","volume":"8","author":"J Epeirier","year":"1996","unstructured":"Epeirier J, Pageaux GP, Coste V, Perrigault PF, Banc P, Larrey D, Michel H (1996) Fulminant hepatitis after carbimazole and propranolol administration. Eur J Gastroenterol Hepatol 8:287\u2013288","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1208_CR92","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/1471-230X-10-93","volume":"10","author":"C Shen","year":"2010","unstructured":"Shen C, Zhao CY, Liu F, Wang YD, Yu J (2010) Acute-on-chronic liver failure due to thiamazole in a patient with hyperthyrdoidism and trilogy of Fallot: case report. BMC Gastroenterol 10:93","journal-title":"BMC Gastroenterol"},{"key":"1208_CR93","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/bcp.12336","volume":"78","author":"M-T Wang","year":"2014","unstructured":"Wang M-T, Lee W-J, Huang T-Y, Chu C-L, Hsieh C-H (2014) Antithyroid drug-related hepatotoxicity in hyperthyroid patients: a population.based cohort study. Br J Clin Pharmacol 78:619\u2013629","journal-title":"Br J Clin Pharmacol"},{"key":"1208_CR94","doi-asserted-by":"publisher","first-page":"204","DOI":"10.2174\/157488609789006912","volume":"4","author":"L Gallelli","year":"2009","unstructured":"Gallelli L, Staltari O, Palleria C, De Sarro G, Ferraro M (2009) Hepatotoxicity induced by methimazole in a previously healthy patient. Curr Drug Saf 4:204\u2013206","journal-title":"Curr Drug Saf"},{"key":"1208_CR95","doi-asserted-by":"publisher","first-page":"3260","DOI":"10.1210\/jc.2009-2546","volume":"95","author":"S Rivkees","year":"2010","unstructured":"Rivkees S, Szarfman A (2010) Dissimilar hepatotoxicity profiles of propylthiouracil and methimazole in children. J Clin Endocrinol Metab 95:3260\u20133267","journal-title":"J Clin Endocrinol Metab"},{"key":"1208_CR96","first-page":"200","volume":"5","author":"Y Hung","year":"1999","unstructured":"Hung Y, Yu WK, Chow E (1999) Delayed cholestatic hepatitis due to methimazole. Hong Kong Med J 5:200\u2013201","journal-title":"Hong Kong Med J"},{"key":"1208_CR97","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s12020-009-9305-9","volume":"37","author":"M Zhang","year":"2010","unstructured":"Zhang M, Zhou H, He R, Di F, Yang L, Yang T (2010) Steroids for the treatment of methimazole-induced severe cholestatic jaundice in a 74-year-old woman with type 2 diabetes. Endocrine 37:241\u2013243","journal-title":"Endocrine"},{"key":"1208_CR98","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s40618-018-0884-2","volume":"41","author":"F Pacini","year":"2018","unstructured":"Pacini F, Basolo F, Bellantone R, Boni G, Cannizzaro MA, De Palma M, Durante C, Elisei R, Fadda G, Frasoldati A, Fugazzola L, Guglielmi R, Lombardi CP, Miccoli P, Papini E, Pellegriti G, Pezzullo L, Pontecrovi A, Salvatori M, Seregni E, Vitti P (2018) Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian Societies. J Endocrinol Invest 41:849\u2013876","journal-title":"J Endocrinol Invest"},{"key":"1208_CR99","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1756-6614-6-4","volume":"6","author":"NP Jhummon","year":"2013","unstructured":"Jhummon NP, Tohooloo B, Qu S (2013) Iodine-131 induced hepatotoxicity in previously healthy patients with Graves\u2019 disease. Thyroid Res 6:4","journal-title":"Thyroid Res"},{"key":"1208_CR100","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3350\/cmh.2015.0037","volume":"22","author":"CW Kim","year":"2016","unstructured":"Kim CW, Park JS, Oh SH (2016) Drug-induced liver injury caused by iodine-131. Clin Mol Hepatol 22:272\u2013275","journal-title":"Clin Mol Hepatol"},{"key":"1208_CR101","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12876-015-0281-7","volume":"15","author":"R Lin","year":"2015","unstructured":"Lin R, Banafea O (2015) I-131 remnant ablation after thyroidectomy induced hepatotoxicity in a case of thyroid cancer. BMC Gastroenterol 15:56","journal-title":"BMC Gastroenterol"},{"key":"1208_CR102","doi-asserted-by":"publisher","first-page":"263","DOI":"10.4158\/EP12077.OR","volume":"19","author":"HA Ferris","year":"2013","unstructured":"Ferris HA, Williams G, Parker JA, Garber JR (2013) Therapeutic implications of diffuse hepatic uptake following I-131 therapy for differentiated thyroid cancer. Endocr Pract 19:263\u2013267","journal-title":"Endocr Pract"},{"key":"1208_CR103","unstructured":"World Health Organization. Global Hepatitis Report, 2017. https:\/\/apps.who.int\/ iris\/bitstream\/10665\/255016\/1\/ 9789241565455"},{"key":"1208_CR104","first-page":"812","volume":"20","author":"MK Shaikh","year":"2012","unstructured":"Shaikh MK, Samo JA, Devrajani BR, Shah SZA (2012) Extra hepatic manifestations of patients with chronic hepatitis C. World Appl Sci J 20:812\u2013817","journal-title":"World Appl Sci J"},{"key":"1208_CR105","doi-asserted-by":"publisher","first-page":"83","DOI":"10.4254\/wjh.v8.i2.83","volume":"8","author":"F Pastore","year":"2016","unstructured":"Pastore F, Martocchia A, Stefanelli M, Prunas P, Giordano S, Toussan L, Devito A, Falaschi P (2016) Hepatitis C virus infection and thyroid autoimmune disorders: a model of interactions between the host and the environment. World J Hepatol 8:83\u201391","journal-title":"World J Hepatol"},{"key":"1208_CR106","doi-asserted-by":"publisher","first-page":"227","DOI":"10.15403\/jgld.2014.1121.252.chc","volume":"25","author":"Y Shen","year":"2016","unstructured":"Shen Y, Wang X-L, Xie J-P, Shao J-G, Lu Y-H, Zhang S, Qin G (2016) Thyroid disturbance in patients with chronic hepatitis C infection: a systematic review and meta-analysis. J Gastroenterol Liver Dis 25:227\u2013234","journal-title":"J Gastroenterol Liver Dis"},{"key":"1208_CR107","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1089\/thy.2006.16.563","volume":"16","author":"A Antonelli","year":"2006","unstructured":"Antonelli A, Ferri P, Fallahi P, Ferrari SM, Ghinoi A, Rotondi M, Ferrannini E (2006) Thyroid disorders in chronic hepatitis C virus infection. Thyroid 16:563\u2013572","journal-title":"Thyroid"},{"key":"1208_CR108","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3892\/etm.2014.1709","volume":"8","author":"X-R Mao","year":"2014","unstructured":"Mao X-R, Zhang L-T, Chen H, Xiao P, Zhang Y-C (2014) Possible factors affecting thyroid dysfunction in hepatitis C virus-infected untreated patients. Exp Ther Med 8:133\u2013140","journal-title":"Exp Ther Med"},{"key":"1208_CR109","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1097\/MCG.0b013e318184a470","volume":"43","author":"HG Hass","year":"2009","unstructured":"Hass HG, Klein R, Nehls O, Kaiser S (2009) Thyroid disorders and occurrence of Nonorgan-Specific Autoantibodies (NOSA) in patients with chronic hepatitis C before and during antiviral induction therapy with consensus interferon (interferon alfacon-1). J Clin Gastroenterol 43:470\u2013476","journal-title":"J Clin Gastroenterol"},{"key":"1208_CR110","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1046\/j.1365-2265.1999.00686.x","volume":"50","author":"M-J Huang","year":"1999","unstructured":"Huang M-J, Tsai L-S, Huang B-Y, Sheen I-S, Yeh C-T, Liaw Y-F (1999) Prevalence and significance of thyroid autoantibodies in patients with chronic hepatitis virus infection: a prospective controlled study. Clin Endocrinol 50:503\u2013509","journal-title":"Clin Endocrinol"},{"key":"1208_CR111","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1089\/thy.2012.0507","volume":"23","author":"JT Blackard","year":"2013","unstructured":"Blackard JT, Kong L, Huber AK, Tomer Y (2013) Hepatitis C virus infection of a thyroid cell line: implications for pathogenesis of hepatitis C virus and thyroiditis. Thyroid 23:863\u2013870","journal-title":"Thyroid"},{"key":"1208_CR112","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jaut.2008.08.001","volume":"31","author":"N Akeno","year":"2008","unstructured":"Akeno N, Blackard JT, Tomer Y (2008) HCV E2 protein binds directly to thyroid cells and induces IL-8 production: a new mechanism for HCV induced thyroid autoimmunity. J Autoimmun 31:339\u2013344","journal-title":"J Autoimmun"},{"key":"1208_CR113","doi-asserted-by":"publisher","first-page":"980942","DOI":"10.1155\/2012\/980942","volume":"2012","author":"AL Zignego","year":"2012","unstructured":"Zignego AL, Giannini C, Gragnani L (2012) HCV and lymphoproliferation. Clin Dev Immunol 2012:980942","journal-title":"Clin Dev Immunol"},{"key":"1208_CR114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajg.2017.01.003","volume":"18","author":"P Wang","year":"2017","unstructured":"Wang P, Jing Z, Liu C, Xu M, Wang P, Wang X, Yin Y, Cui Y, Ren D, Rao X (2017) Hepatitis C virus infection and risk of thyroid cancer: a systematic review and meta-analysis. Arab J Gastroenterol 18:1\u20135","journal-title":"Arab J Gastroenterol"},{"key":"1208_CR115","first-page":"713","volume":"17","author":"A Eshraghian","year":"2014","unstructured":"Eshraghian A, Taghavi SA (2014) Systematic review: endocrine abnormalities in patients with liver cirrhosis. Arch Iran Med 17:713\u2013721","journal-title":"Arch Iran Med"},{"key":"1208_CR116","first-page":"34","volume":"23","author":"A Mobin","year":"2016","unstructured":"Mobin A, Haroon H, Shaikh H, Qureshi F, Ali M (2016) Decompensated cirrhosis. Thyroid hormone levels in patients. Prof Med J 23:34\u201338","journal-title":"Prof Med J"},{"key":"1208_CR117","first-page":"645","volume":"22","author":"P Punekar","year":"2018","unstructured":"Punekar P, Sharma AK, Jain A (2018) A study of thyroid dysfunction in cirrhosis of liver and correlation with severity of liver disease. Int J Endocrinol Metab 22:645\u2013650","journal-title":"Int J Endocrinol Metab"},{"key":"1208_CR118","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/17843286.2016.1215641","volume":"72","author":"S Vincken","year":"2017","unstructured":"Vincken S, Reynaert H, Schettecatte J, Kaufman L, Velkeniers B (2017) Liver cirrhosis and thyroid function: friend or foe ? Acta Clin Belg 72:85\u201390","journal-title":"Acta Clin Belg"},{"key":"1208_CR119","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/qjmed\/hch088","volume":"97","author":"A Antonelli","year":"2004","unstructured":"Antonelli A, Ferri C, Fallahi P, Giuggioli D, Nesti C, Longombardo G, Fadda P, Pampana A, Maccheroni M, Ferrannini E (2004) Thyroid involvement in patients with overt HCV-related mixed cryoglobulinaemia. QJM Int J Med 97:499\u2013506","journal-title":"QJM Int J Med"},{"key":"1208_CR120","doi-asserted-by":"publisher","first-page":"126","DOI":"10.4236\/ojemd.2016.63017","volume":"6","author":"MA El-Feki","year":"2016","unstructured":"El-Feki MA, Abdalla NH, Atta MI, Ibrahim AA (2016) Serum levels of thyroid hormones in patients with chronic hepatitis C virus infection. Open J Endocr Metab Dis 6:126\u2013134","journal-title":"Open J Endocr Metab Dis"},{"key":"1208_CR121","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/j.1478-3231.2009.02003.x","volume":"29","author":"MG Silveira","year":"2009","unstructured":"Silveira MG, Mendes FD, Diehl NN, Enders FT, Linder KD (2009) Thyroid dysfunction in primary biliary cirrhosis, primary sclerosing cholangitis and non-alcoholic fatty liver disease. Liver Int 29:1094\u20131100","journal-title":"Liver Int"},{"key":"1208_CR122","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2147\/JHC.S61146","volume":"3","author":"J Balogh","year":"2016","unstructured":"Balogh J, Victor D III, Asham EH, Burroughs SG, Boktour M, Saharia A, Li X, Ghobrial RM, Monsour HP Jr (2016) Hepatocellular carcinoma: a review. J Hepatocell Carcinoma 3:41\u201353","journal-title":"J Hepatocell Carcinoma"},{"key":"1208_CR123","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1002\/hep.22793","volume":"49","author":"MM Hassan","year":"2009","unstructured":"Hassan MM, Kaseb A, Li D, Patt YZ, Vauthey JN, Thomas MB, Curley SA, Spitz MR, Sherman SI, Abdalla EK, Davila M, Lozano RD, Hassan DM, Chan W, Brown TD, Abbruzzese JL (2009) Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States. Hepatology 49:1563\u20131570","journal-title":"Hepatology"},{"key":"1208_CR124","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.cgh.2006.07.011","volume":"5","author":"A Reddy","year":"2007","unstructured":"Reddy A, Dash C, Leerapun A, Mettler TA, Stadheim LM, Lazaridis KN, Roberts RO, Roberts LR (2007) Hypothyroidism: a possible risk factor for liver cancer in patients with no known underlying cause of liver disease. Clin Gastroenterol Hepatol 5:118\u2013123","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"1208_CR125","doi-asserted-by":"publisher","first-page":"e0181878","DOI":"10.1371\/journal.pone.0181878","volume":"12","author":"M Pinter","year":"2017","unstructured":"Pinter M, Haupt L, Hucke F, Bota S, Bucsics T, Trainer M, Peck-Radosavljevic M, Sieghart W (2017) The impact of thyroid hormones on patients with hepatocellular carcinoma. PLoS ONE 12(8):e0181878. https:\/\/doi.org\/10.1371\/journal.pone.0181878","journal-title":"PLoS ONE"},{"key":"1208_CR126","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/BF00571690","volume":"381","author":"N Nagasue","year":"1996","unstructured":"Nagasue N, Ohmori H, Hashimoto N, Tachibana M, Kubota H, Uchida M, Yu L (1996) Thyroxine-binding globulin and thyroid hormones after resection of hepatocellular carcinoma. Langenbecks Arch Chir 381:225\u2013227","journal-title":"Langenbecks Arch Chir"},{"key":"1208_CR127","first-page":"106","volume":"100","author":"PL Tsou","year":"2001","unstructured":"Tsou PL, Chang TC (2001) Ultrasonographic and cytologic findings of metastatic cancer in the thyroid gland. J Formos Med Assoc 100:106\u2013112","journal-title":"J Formos Med Assoc"},{"key":"1208_CR128","first-page":"280","volume":"37","author":"HH Liang","year":"2007","unstructured":"Liang HH, Wu CH, Tam KW, Chai CY, Lin SE, Chen SC (2007) Thyroid metastasis in a patient with hepatocellular carcinoma: case report and review of literature. Ann Clin Lab Sci 37:280\u2013284","journal-title":"Ann Clin Lab Sci"},{"key":"1208_CR129","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1159\/000318858","volume":"4","author":"T Toshima","year":"2010","unstructured":"Toshima T, Taketomi A, Shirabe K, Takeishi K, Motomura T, Mano Y (2010) Solitary asymptomatic thyroid metastasis from hepatocellular carcinoma detected by FDG-PET\/CT. Case Rep Gastroenterol 4:279\u2013285","journal-title":"Case Rep Gastroenterol"},{"key":"1208_CR130","first-page":"43","volume":"19","author":"T Masuda","year":"2001","unstructured":"Masuda T, Fukuya T, Ono M, Mitsuyama S, Toyoshima S (2001) Thyroid metastasis from hepatocellular carcinoma as an initial presentation: a case report. Radiat Med 19:43\u201346","journal-title":"Radiat Med"},{"key":"1208_CR131","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.ejso.2004.03.012","volume":"30","author":"K Wood","year":"2004","unstructured":"Wood K, Vini L, Harmer C (2004) Metastases to the thyroid gland: the Royal Marsden experience. Eur J Surg Oncol 30:583\u2013588","journal-title":"Eur J Surg Oncol"},{"key":"1208_CR132","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ijscr.2011.11.001","volume":"3","author":"MH Park","year":"2012","unstructured":"Park MH, Cho JS, Lee JS, Kim HK, Yoon JH (2012) Thyroid gland metastasis arising from primary liver cholangiocarcinoma: the first case report involving surgical operation. Int J Surg Case Rep 3:78\u201381","journal-title":"Int J Surg Case Rep"},{"key":"1208_CR133","doi-asserted-by":"publisher","first-page":"56","DOI":"10.4143\/crt.2009.41.1.56","volume":"41","author":"WK Bae","year":"2009","unstructured":"Bae WK, Shim HJ, Choi YD, Kim JW, Cho SH, Kang HC, Chung IJ (2009) Severe hypothyroidism induced by thyroid metastasis of cholangiocarcinoma. Cancer Res Treat 41:56\u201358","journal-title":"Cancer Res Treat"},{"key":"1208_CR134","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0140-6736(97)06088-1","volume":"351","author":"Reichard O, Norkrans G, Fryden A, Braconier JH, Sonnerborg A, Weiland O, Swedish Study Group","year":"1998","unstructured":"Reichard O, Norkrans G, Fryden A, Braconier JH, Sonnerborg A, Weiland O, Swedish Study Group (1998) Randomized, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. Lancet 351:83\u201387","journal-title":"Lancet"},{"key":"1208_CR135","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","volume":"358","author":"MP Manns","year":"2001","unstructured":"Manns MP, McHutchinson JG, Gordon SC, Rustqi VK, Shiffman M, Reindollar R, Goodman ZD, Koury K, Ling M, Albrecht JK (2001) Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358:958\u2013965","journal-title":"Lancet"},{"key":"1208_CR136","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1056\/NEJMoa020047","volume":"347","author":"MW Fried","year":"2002","unstructured":"Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Gon\u00e7ales FL Jr, H\u00e4ussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J (2002) Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347:975\u2013982","journal-title":"N Engl J Med"},{"key":"1208_CR137","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jhep.2018.03.026","volume":"69","author":"European Association for the Study of the Liver","year":"2018","unstructured":"European Association for the Study of the Liver (2018) EASL Recommendations on Treatment of Hepatitis C 2018. J Hepatol 69:461\u2013511","journal-title":"J Hepatol"},{"key":"1208_CR138","doi-asserted-by":"publisher","first-page":"752","DOI":"10.2174\/1389450116666151102095708","volume":"18","author":"A Antonelli","year":"2017","unstructured":"Antonelli A, Pistello M (2017) New therapies, markers and therapeutic targets in HCV chronic infection and HCV extrahepatic manifestations. Curr Drugs Targets 18:752\u2013755","journal-title":"Curr Drugs Targets"},{"key":"1208_CR139","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1002\/jmv.25319","volume":"91","author":"B Wahid","year":"2019","unstructured":"Wahid B, Waqar M, Rasool N, Wasim M, Khalid I, Idrees M (2019) Prevalence of thyroid stimulating hormone dysfunction among sofosbuvir-treated HCV-infected patients: a real-world clinical experience. J Med Virol 91:514\u2013517","journal-title":"J Med Virol"},{"key":"1208_CR140","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/S0002-9343(96)00259-8","volume":"101","author":"E Roti","year":"1996","unstructured":"Roti E, Minelli R, Giuberti T, Marchelli S, Schianchi C, Gardini E, Salvi M, Fiaccadori F, Ugolotti G, Neri TM, Braverman LE (1996) Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha. Am J Med 101:482\u2013487","journal-title":"Am J Med"},{"key":"1208_CR141","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1007\/BF01296413","volume":"36","author":"B Berris","year":"1991","unstructured":"Berris B, Feinman SV (1991) Thyroid dysfunction and liver injury following alpha-interferon treatment of chronic viral hepatitis. Dig Dis Sci 36:1657\u20131660","journal-title":"Dig Dis Sci"},{"key":"1208_CR142","doi-asserted-by":"publisher","first-page":"3656","DOI":"10.1210\/jc.2004-0627","volume":"89","author":"C Carella","year":"2004","unstructured":"Carella C, Mazziotti G, Amato G, Braverman LE, Roti E (2004) Clinical review 169: Interferon-alpha-related thyroid disease: pathophysiological, epidemiological and clinical aspects. J Clin Endocrinol Metab 89:3656\u20133661","journal-title":"J Clin Endocrinol Metab"},{"key":"1208_CR143","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1089\/thy.1997.7.891","volume":"7","author":"LKH Koh","year":"1997","unstructured":"Koh LKH, Greenspan FS, Yeo PPB (1997) Interferon-\u03b1 induced thyroid dysfunction: three clinical presentation and review of the literature. Thyroid 7:891\u2013896","journal-title":"Thyroid"},{"key":"1208_CR144","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1046\/j.1365-2796.2002.00974.x","volume":"251","author":"O Dalgard","year":"2002","unstructured":"Dalgard O, Bj\u00f8ro K, Hellum K, Myrvang B, Bj\u00f8ro T, Haug E, Bell H (2002) Thyroid dysfunction during treatment of chronic hepatitis C with interferon-\u03b1: no association with either interferon dosage or efficacy of therapy. J Int Med 251:400\u2013406","journal-title":"J Int Med"},{"key":"1208_CR145","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1210\/jcem.83.3.4624","volume":"83","author":"P Laurberg","year":"1998","unstructured":"Laurberg P, Pedersen KM, Hreidarsson A, Sigfusson N, Iversen E, Knudsen PR (1998) Iodine intake and the pattern of thyroid disorders: a comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark. J Clin Endocrinol Metab 83:765\u2013769","journal-title":"J Clin Endocrinol Metab"},{"key":"1208_CR146","doi-asserted-by":"crossref","first-page":"394","DOI":"10.47102\/annals-acadmedsg.V40N9p394","volume":"40","author":"V Themistoklis","year":"2011","unstructured":"Themistoklis V, Panagiotis A, Georgios N, Konstantinos S, Kaliopi P, Nikolaos G, Eleni O-K, Konstantinos K, Aristidis S, Aristidis D (2011) Thyroid dysfunction and long-term outcome during and after interferon-alpha therapy in patients with chronic hepatitis C. Ann Acad Med Singapore 40:394\u2013400","journal-title":"Ann Acad Med Singapore"},{"key":"1208_CR147","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1089\/105072503322238809","volume":"13","author":"MF Prummel","year":"2003","unstructured":"Prummel MF, Laurberg P (2003) Interferon-\u03b1 and autoimmunity thyroid disease. Thyroid 13:547\u2013551","journal-title":"Thyroid"},{"key":"1208_CR148","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1590\/S1413-86702011000500006","volume":"15","author":"MHP Pavan","year":"2011","unstructured":"Pavan MHP, Pavin EJ, Gon\u00e7ales FL Jr, Wittman DEZ (2011) Virus C genotype predisposes to primary hypothrydism during interferon-\u03b1 treatment for chronic hepatitis C. Braz J Infect Dis 15:449\u2013456","journal-title":"Braz J Infect Dis"},{"key":"1208_CR149","doi-asserted-by":"publisher","first-page":"i1","DOI":"10.1136\/gut.49.suppl_1.I1","volume":"49","author":"JCL Booth","year":"2011","unstructured":"Booth JCL, O'Grady J, Neuberger J, Royal College of Physicians of London, British Society of Gastroenterology (2011) Clinical guidelines on the management of hepatitis C. Gut 49:i1\u2013i21","journal-title":"Gut"},{"key":"1208_CR150","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1053\/j.gastro.2005.11.011","volume":"130","author":"JL Dienstang","year":"2006","unstructured":"Dienstang JL, McHtchinson JG (2006) American gastroenterological association medical position statement on the management of hepatitis C. Gastroenterology 130:225\u2013230","journal-title":"Gastroenterology"},{"key":"1208_CR151","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/hep.1840180205","volume":"18","author":"A Tran","year":"1993","unstructured":"Tran A, Quaranta JF, Benzaken S, Thiers V, Chau HT, Hastier P, Regnier D, Dreyfus G, Pradier C, Sadoul JL, Hebutier X, Rampa P (1993) High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy. Hepatology 18:253\u2013257","journal-title":"Hepatology"},{"key":"1208_CR152","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1530\/eje.0.1320587","volume":"132","author":"D Preziati","year":"1995","unstructured":"Preziati D, La Rosa L, Covini G, Marcelli R, Rescalli S, Persani L, Del Ninno E, Meroni PL, Colombo M, Beck-Peccoz P (1995) Autoimmunity and thyroid function in patients with chronic active epatitis treated with recombinant interferon alpha-2a. Eur J Endocrinol 132:587\u2013593","journal-title":"Eur J Endocrinol"},{"key":"1208_CR153","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S1542-3565(05)00018-2","volume":"3","author":"L Muratori","year":"2005","unstructured":"Muratori L, Bogdanos DP, Muratori P, Lenzi M, Granito A, Ma Y, Milei-Vergani G, Bianchi FB, Vergani D (2005) Susceptibility to thyroid disorders in hepatitis C. Clin Gastroenterol Hepatol 3:595\u2013603","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1208_CR154","first-page":"6518","volume":"13","author":"DV Stefanova-Petrova","year":"2007","unstructured":"Stefanova-Petrova DV, Tzvetanska AH, Naumova EJ, Mihailova AP, Hadiiev EA, Dikova RP, Vukov MI, Tchernev KG (2007) Chronic hepatitis C virus infection: prevalence of extrahepatic manifestations and association with cryoglobulinemia in Bulgarian patients. W J Gastroenterol 13:6518\u20136528","journal-title":"W J Gastroenterol"},{"key":"1208_CR155","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/j.1365-2265.1993.tb02423.x","volume":"39","author":"E Baudin","year":"1993","unstructured":"Baudin E, Marcellin P, Pouteau M, Colas-Linhart N, Le Floch JP, Lemmonier C, Benhamou J-P, Bok B (1993) Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C. Clin Endocrinol (Oxf) 39:657\u2013661","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1208_CR156","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1046\/j.1365-2265.1996.751768.x","volume":"44","author":"M Marazuela","year":"1996","unstructured":"Marazuela M, Garc\u00eca-Buey L, Gonz\u00e1les-Fern\u00e1ndez B, Garc\u00eca-Monz\u00f3n C, Arranz A, Borque MJ, Moreno-Otero R (1996) Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy. Clin Endocrinol (Oxford) 44:635\u2013642","journal-title":"Clin Endocrinol (Oxford)"},{"key":"1208_CR157","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1517\/14656566.2.8.1317","volume":"2","author":"JN Snell","year":"2001","unstructured":"Snell JN (2001) Ribavirin-current status of a broad spectrum antiviral agent. Expert Opin Pharmacother 2:1317\u20131324","journal-title":"Expert Opin Pharmacother"},{"key":"1208_CR158","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1007\/BF03345087","volume":"25","author":"G Mazziotti","year":"2002","unstructured":"Mazziotti G, Sorvillo F, Stornaiuolo G, Rotondi M, Morisco F, Ruberto M, Cioffi M, Amato G, Caporaso N, Gaeta GB, Carella C (2002) Temporal relationship between the appearance of thyroid autoantibodies and development of destructive thyroiditis in patients undergoing treatment with two different type-1 interferons for HCV-related chronic epatitis: a prospective study. J Endocrinol Invest 25:624\u2013630","journal-title":"J Endocrinol Invest"},{"key":"1208_CR159","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1530\/eje.0.1460743","volume":"146","author":"C Carella","year":"2002","unstructured":"Carella C, Mazziotti G, Morsico F, Rotondi M, Ciuffi M, Tuccilli C, Sorvillo F, Caporaso N, Amato G (2002) The addition of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism. Eur J Endocrinol 146:743\u2013749","journal-title":"Eur J Endocrinol"},{"key":"1208_CR160","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1001\/archinte.164.21.2371","volume":"164","author":"EJ Bini","year":"2004","unstructured":"Bini EJ, Mehandru S (2004) Incidence of thyroid dysfunction during interferon alfa-2b and ribavirin therapy in men with chronic hepatitis C. A prospective cohort study. Arch Intern Med 164:2371\u20132376","journal-title":"Arch Intern Med"},{"key":"1208_CR161","doi-asserted-by":"publisher","first-page":"52","DOI":"10.4158\/EP.7.1.52","volume":"7","author":"DL Ward","year":"2001","unstructured":"Ward DL, Bing-You RG (2001) Autoimmune thyroid dysfunction induced by interferon-alfa treatment for chronic hepatitis C: screening and monitoring recommendations. Endocr Pract 7:52\u201358","journal-title":"Endocr Pract"},{"key":"1208_CR162","first-page":"284","volume":"4","author":"R Parana","year":"2000","unstructured":"Parana R, Cruz M, Santos-Jesus R, Ferreira K, Codes L, Cruz T (2000) Thyroid disease in HCV carriers undergoing antiviral therapy with interferon plus ribavirin. Braz J Infect Dis 4:284\u2013290","journal-title":"Braz J Infect Dis"},{"key":"1208_CR163","first-page":"472","volume":"22","author":"HA Tran","year":"2007","unstructured":"Tran HA, Attia JR, Jones TL, Batey RG (2007) Pegylated interferon-a2b in combination with ribavirin does not aggravate thyroid dysfunction in comparison to regular interferon-a2b in a hepatitis C population: meta-analysis. Hepatology 22:472\u2013476","journal-title":"Hepatology"},{"key":"1208_CR164","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1159\/000496439","volume":"8","author":"M Bouattour","year":"2019","unstructured":"Bouattour M, Mehta N, He AR, Cohen EI, Nault J-C (2019) Systemic treatment for advanced hepatocellular carcinoma. Liver Cancer 8:341\u2013358","journal-title":"Liver Cancer"},{"key":"1208_CR165","doi-asserted-by":"publisher","first-page":"126","DOI":"10.4274\/jcrpe.v2i3.126","volume":"2","author":"L van Doorn","year":"2010","unstructured":"van Doorn L, Eskens FA, Visser TJ, van der Lugt A, Mathijssen RH, Peeters RP (2010) Sorafenib induced thyroiditis in two patients with hepatocellular carcinoma. J Clin Res Pediatr Endocrinol 2:126\u2013130","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"1208_CR166","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1210\/jc.2016-4025","volume":"102","author":"CM Beukhof","year":"2017","unstructured":"Beukhof CM, van Doorn L, Visser TJ, Bins S, Visser WE, van Heerebeek R, van Kemenade FJ, de Rijke YB, de Herder WW, Chaker L, Mathijsen RH, Peeters RP (2017) Sorafenib-induced changes in thyroid hormone levels in patients treated for hepatocellular carcinoma. J Clin Endocrinol Metab 102:2922\u20132929","journal-title":"J Clin Endocrinol Metab"},{"key":"1208_CR167","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s40618-018-0984-z","volume":"42","author":"RM Ruggeri","year":"2019","unstructured":"Ruggeri RM, Campenni A, Giuffrida G, Trimboli P, Giovanella L, Trimarchi F, Cannav\u00f2 S (2019) Endocrine and metabolic adverse effects of immune checkpoint inhibitors: an overview (what endocrinologists should know). J Endocrinol Invest 42:745\u2013756","journal-title":"J Endocrinol Invest"},{"key":"1208_CR168","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-019-01112-8","author":"EM Presotto","year":"2019","unstructured":"Presotto EM, Rastrelli G, Desideri I, Scotti V, Gunnella S, Pimpinelli N, Vaccher E, Bearz A, Di Costanzo F, Bruggia M, Mini E, Maggio M, Peri A (2019) Endocrine toxicity in cancer patients treated with nivolumab or pembrolizumab: results of a large multicentre study. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-019-01112-8","journal-title":"J Endocrinol Invest"},{"key":"1208_CR169","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/cen.13063","volume":"85","author":"MN Joshi","year":"2016","unstructured":"Joshi MN, Whitelaw BC, Palomar MT, Wu Y, Carroll PV (2016) Immune checkpoint inhibitor-related hypophysitis and endocrine dysfunction: clinical review. Clin Endocrinol (Oxford) 85:331\u2013339","journal-title":"Clin Endocrinol (Oxford)"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01208-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-020-01208-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01208-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T10:46:05Z","timestamp":1695897965000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-020-01208-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,12]]},"references-count":169,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["1208"],"URL":"https:\/\/doi.org\/10.1007\/s40618-020-01208-6","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,12]]},"assertion":[{"value":"22 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any study with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"For this type of study, formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}